Effect of SMYD3 over-expression on miR-124 expression and proliferation ability in human intrahepatic cholangiocarcinoma cells

AIM：To explore the effect of SET and MYND domain-containing protein 3 (SMYD3) over-expression on miR-124 expression and proliferation ability of human intrahepatic cholangiocarcinoma cells. METHODS：Transient transfection of SMYD3 eukaryotic expression plasmid into human intrahepatic cholangiocarcinoma cell line HCCC-9810 were performed. The expression of SMYD3 at mRNA and protein levels was measured by qRT-PCR and Western blotting, respectively. The expression of miR-124 was detected by qRT-PCR, and the methylation status of miR-124 gene was determined by methylation-specific PCR. Cell proliferation was examined by CCK-8 assay and colony formation experiment. RESULTS：After transfected with SMYD3 eukaryotic expression plasmid, the over-expression of SMYD3 in HCCC-9810 cells was observed. Compared with the blank cells, the expression level of miR-124 was significantly decreased and miR-124 gene promoter methylation was significantly increased. In addition, SMYD3 over-expression significantly promoted the proliferation of HCCC-9810 cells. CONCLUSION：The transient transfection of SMYD3 plasmid increases the methylation of miR-124 gene promoter and induces under-expression of miR-124. Over-expression of SMYD3 promotes the proliferation of cholangiocarcinoma cells.     

Detection of miR-122 expression in serum by Taqman probe real-time fluorescence quantitative PCR and its clinical significance

AIM: To detect the serum level of miR-122 expression by the technique of Taqman probe real-time fluorescence quantitative PCR for identifying its clinical significance. METHODS: The stem-loop RT primer, PCR primer and Taqman probe of miR-122 and U6 snRNA were designed. The expression of miR-122 in the serum samples of 27 cases of preoperative hepatocellular carcinoma (HCC), 15 cases of hepatitis B, 15 cases of hepatitis C, 15 cases of healthy control (HC), 11 cases of postoperative hepatocellular carcinoma (PHCC) and 10 cases of recurrence after postoperative hepatocellular carcinoma was detected by Taqman probe real-time fluorescence quantitative PCR. U6 snRNA was used as the internal control. RESULTS: The results showed that the method of Taqman probe real-time fluorescence quantitative PCR could detect the amplification signal of serum miR-122. The expression level of serum miR-122 in the patients with HCC, hepatitis B, hepatitis C and recurrence was higher than that in HC and the patients with PHCC. Meanwhile, the serum level of miR-122 in the patients with hepatitis C was higher than that in the patients with HCC, hepatitis B and recurrence. However, no difference of miR-122 expression level among HCC, hepatitis B and recurrent patients was observed. The miR-122 level was lower in PHCC patients than that in HCC and recurrent patients. In hepatitis B virus surface antigen (HBsAg) and/or hepatitis B virus e antigen (HBeAg) positive patients, the miR-122 level was higher than that in the negative ones. The miR-122 level in hepatitis C antibody (HCV-Ab) positive patients was raised compared with the negative ones. The serum level of alanine aminotransferase (ALT) was positively correlated with the serum level of miR-122 (r=0.34, P<0.05). The miR-122 expression level in the patients with serum AFP≥400 μg/L was higher than that in the patients with serum AFP<400 μg/L. CONCLUSION: The method of Taqman probe real-time fluorescence quantitative PCR can detect the serum level of miR-122 expression. Serum miR-122 might be used as a new biomarker of liver diseases, especially in the early diagnosis of primary hepatocellular carcinoma, the curative effect of surgical operation and the prognosis.     

miRNA-125b在牛病毒性腹泻病毒感染MDBK细胞中诱导细胞凋亡的研究

为研究miRNA-125b在致细胞病变牛病毒性腹泻病毒(cpBVDV)感染牛肾细胞(MDBK细胞)过程中诱导细胞凋亡的机制,本研究将cpBVDV感染MDBK细胞,并将构建的pcDNA-miR-125b转染MDBK细胞作为阳性对照.采用荧光定量RT-PCR (qRT-PCR)检测细胞中miRNA-125b和B细胞淋巴瘤/白血病-2(Bcl-2) mRNA转录水平,通过流式细胞仪检测细胞凋亡率.检测结果显示,cpBVDV感染MDBK细胞12 h和24 h,细胞中miRNA-125b的转录水平分别为正常细胞对照组的2.01倍和3.85倍,Bcl-2 mRNA的转录水平分别为对照组的0.71倍和0.31倍;pcDNA-miR-125b转染MDBK细胞48 h后,Bcl-2 mRNA的转录水平为正常细胞对照组的0.42倍.细胞凋亡检测结果显示,cpBVDV感染MDBK细胞12 h和24 h,细胞的凋亡率分别为15.06％和36.43％;pcDNA3.1-miR-125b转染48 h,细胞的凋亡率为25.56％.结果表明miRNA-125b在cpBVDV感染MDBK细胞过程中能够通过抑制抗凋亡基因Bcl-2 mRNA转录水平从而诱导细胞产生凋亡.     

不同地方猪种背部皮下脂肪中miR-206差异表达研究

试验采用荧光定量PCR技术(QRT-PCR)对6个四川省地方猪种背部皮下脂肪中miR-206的差异表达情况进行测定和分析。结果表明:藏猪miR-206相对表达量最高,成华猪次之,青峪猪最低;藏猪miR-206相对表达量显著高于内江猪(P<0.05),极显著高于丫杈猪和青峪猪(P<0.01)。     

奶牛OLR1 3′UTR A223C多态的生物学信息分析

[目的]探索氧化型低密度脂蛋白受体OLR13′UTR A223C多态与奶牛乳脂率高低紧密关联的分子机制。[方法]用miRanda（1.0）软件装载牛microRNA数据库,预测OLR13′UTR潜在的microRNA。[结果]共预测16个microRNA靶标,OLR13′UTRA223C突变定位于bta-miR-370靶标种子序列的互补区。[结论]由于OLR13′UTRA→C突变导致bta-miR-370靶标的消失,为OLR13′UTR A223C多态与奶牛乳脂率高低紧密关联的分子机制深入研究提供依据。     

miR-15a真核表达载体的构建及鉴定

根据miR-15a成熟体序列合成1对miRNA寡聚单链DNA,克隆到真核表达载体pcDNATM6.2-GW/EmGFP-miR中,构建pcDNATM6.2-GW/EmGFP-miR-15a真核表达载体。瞬时转染肺腺癌A549细胞后,经Real-time PCR证明pcDNATM6.2-GW/EmGFP-miR-15a能有效表达miR-15a。试验结果为进一步研究miR-15a的功能和靶基因鉴定打下了基础。     

miR-142-3p对人乳腺上皮细胞MCF-10A增殖及乳蛋白合成的影响

MicroRNAs(miRNAs)是一类长度约为22 nt的非编码的调控性小RNA,在诸多生命活动中发挥重要作用,如参与调控细胞的增殖、分化、凋亡及肿瘤的发生发展。本试验应用脂质体转染技术抑制miR-142-3p在人乳腺上皮细胞的表达。试验采用实时荧光定量PCR、Western blotting、细胞增殖分析等技术,探索miR-142-3p对人乳腺上皮细胞增殖及乳蛋白合成的影响。结果显示,miR-142-3p沉默后,催乳素受体(prolactin receptor,PRLR)蛋白表达增强,同时,相关通路蛋白AKT、mTOR、STAT5、cyclinD1表达量均增加,细胞增殖能力增强。结果表明,在人乳腺上皮细胞中,miR-142-3p的沉默使PRLR蛋白表达量升高,通过调控AKT、mTOR、STAT5、cyclinD1相关通路蛋白而促进乳蛋白质的合成和乳腺上皮细胞的增殖。     

miR-142-3p对奶山羊乳腺上皮细胞泌乳功能的影响

为确定miR-142-3p对奶山羊乳腺上皮细胞泌乳功能的调节作用,试验选取泌乳期奶山羊乳腺上皮细胞为研究材料,利用脂质体转染技术抑制miR-142-3p的表达,采用实时荧光定量PCR、Western blotting、试剂盒等检测miR-142-3p基因沉寂后其对奶山羊乳腺上皮细胞泌乳功能的影响。结果显示,miR-142-3p基因沉寂后,奶山羊乳腺上皮细胞增殖能力增强,β-酪蛋白及甘油三酯分泌增加。由此可知,miR-142-3p通过抑制靶基因作用,影响奶山羊乳腺上皮细胞增殖、分泌β-酪蛋白及甘油三酯等泌乳功能。